Eureka!
7 clip(s) in playlist
Bristol Myers Squibb CDTO Greg Meyers on biopharma’s AI-enabled future
Greg Meyers, Executive Vice President and Chief Digital & Technology Officer at Bristol Myers Squibb (BMS) discusses how technology can be leveraged to drive outcomes.
30:08
Lykke Hinsch Gylvin on the cutting edge of clinical trial design
Lykke Hinsch Gylvin shares how Boehringer Ingelheim’s innovative clinical trial designs bring therapies to patients faster.
23:48
Genentech’s John Marioni on enhancing drug discovery with data and AI
John Marioni discusses how he and his teams across industries and academia use evolving technologies to bring sophisticated drug therapies to patients.
32:03
J&J’s Ashita Batavia on advancing oncology clinical-trials with data
In this episode of Eureka!, a McKinsey podcast on innovation in life sciences R&D, hosts Navraj Nagra, Alex Devereson, and Meredith Langstaff speak to Ashita Batavia, head of hematology and oncology data sciences, R&D, at Johnson & Johnson Innovative Medicine (J&J). They discuss how real-world data…
32:21
GSK's Kim Branson on driving innovation with AI and machine learning
In this episode, hosts Navraj Nagra and Alex Devereson speak to Kim Branson, senior vice president and global head of AI and machine learning at GSK. They discuss how these emerging technologies are being used to potentially reshape how drugs are developed and about the complexities AI and machine …
27:07
AbbVie’s head of genomics research on the transformative power of AI
In this episode, Howard Jacob, AbbVie’s vice president of genomics research and head of data integration, discusses early adoption of data integration at AbbVie, the challenges of medical silos, and the steps needed to build novel AI and machine learning capabilities with McKinsey’s Alex Devereson,…
19:15
Advancing R&D for chronic diseases with AI: A conversation with Novo Nordisk’s CSO
Marcus Schindler, chief scientific officer, and head of research and early development at Novo Nordisk, shares the ways in which he's leading the company’s efforts to embrace external innovation and expand into new therapeutic areas with AI as a powerful catalyst for progress with McKinsey colleagu…
25:38